|
Name |
Herbarin
|
Molecular Formula | C16H16O6 | |
IUPAC Name* |
3-hydroxy-7,9-dimethoxy-3-methyl-1,4-dihydrobenzo[g]isochromene-5,10-dione
|
|
SMILES |
CC1(CC2=C(CO1)C(=O)C3=C(C2=O)C=C(C=C3OC)OC)O
|
|
InChI |
InChI=1S/C16H16O6/c1-16(19)6-10-11(7-22-16)15(18)13-9(14(10)17)4-8(20-2)5-12(13)21-3/h4-5,19H,6-7H2,1-3H3
|
|
InChIKey |
MQWLANHTCHDMAR-UHFFFAOYSA-N
|
|
Synonyms |
Herbarin; 36379-67-6; 3-hydroxy-7,9-dimethoxy-3-methyl-1,4-dihydrobenzo[g]isochromene-5,10-dione; 3-Hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-5,10-dione; DTXSID70957714; MFCD08274581; AKOS030213199; BS-1592; 1H-Naphtho(2,3-c)pyran-5,10-dione, 3,4-dihydro-3-hydroxy-7,9-dimethoxy-3-methyl-; 3-Hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-naphtho[2,3-c]pyran-5,10-dione
|
|
CAS | 36379-67-6 | |
PubChem CID | 3084629 | |
ChEMBL ID | CHEMBL251913 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 304.29 | ALogp: | 0.8 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 82.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 22 | QED Weighted: | 0.9 |
Caco-2 Permeability: | -5.296 | MDCK Permeability: | 0.00001120 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.108 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.01 |
Blood-Brain-Barrier Penetration (BBB): | 0.044 | Plasma Protein Binding (PPB): | 86.92% |
Volume Distribution (VD): | 1.027 | Fu: | 11.95% |
CYP1A2-inhibitor: | 0.975 | CYP1A2-substrate: | 0.901 |
CYP2C19-inhibitor: | 0.043 | CYP2C19-substrate: | 0.552 |
CYP2C9-inhibitor: | 0.072 | CYP2C9-substrate: | 0.878 |
CYP2D6-inhibitor: | 0.355 | CYP2D6-substrate: | 0.418 |
CYP3A4-inhibitor: | 0.289 | CYP3A4-substrate: | 0.256 |
Clearance (CL): | 6.643 | Half-life (T1/2): | 0.88 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.292 |
Drug-inuced Liver Injury (DILI): | 0.659 | AMES Toxicity: | 0.771 |
Rat Oral Acute Toxicity: | 0.064 | Maximum Recommended Daily Dose: | 0.132 |
Skin Sensitization: | 0.146 | Carcinogencity: | 0.938 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.13 |
Respiratory Toxicity: | 0.553 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003044 | 0.783 | D0C1SF | 0.330 | ||||
ENC000880 | 0.773 | D02LZB | 0.274 | ||||
ENC002709 | 0.579 | D01XWG | 0.273 | ||||
ENC000941 | 0.545 | D09DHY | 0.273 | ||||
ENC006067 | 0.543 | D0N1FS | 0.267 | ||||
ENC002708 | 0.538 | D06GCK | 0.265 | ||||
ENC004459 | 0.525 | D0L1JW | 0.261 | ||||
ENC002752 | 0.489 | D0C9XJ | 0.258 | ||||
ENC002273 | 0.469 | D07VLY | 0.258 | ||||
ENC005584 | 0.464 | D0F7CS | 0.257 |